एपीए उद्धरण

Weiden, P. J., Du, Y., von Moltke, L., Wehr, A., Hard, M., Marandi, M., & Walling, D. P. (2020). Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study. CNS Drugs.

शिकागो स्टाइल उद्धरण

Weiden, Peter J., Yangchun Du, Lisa von Moltke, Angela Wehr, Marjie Hard, Morteza Marandi, और David P. Walling. "Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study." CNS Drugs 2020.

एमएलए उद्धरण

Weiden, Peter J., et al. "Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study." CNS Drugs 2020.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.